Nirav Shah to Leukemia, B-Cell
This is a "connection" page, showing publications Nirav Shah has written about Leukemia, B-Cell.
Connection Strength
0.701
-
Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial. Nat Med. 2020 10; 26(10):1569-1575.
Score: 0.701